Interleukin 6 News and Research

RSS
Interleukin-6 (IL-6) is a protein that in humans is encoded by the "IL6" gene. IL-6 is an interleukin that acts as both a pro-inflammatory and anti-inflammatory cytokine. It is secreted by T cells and macrophages to stimulate immune response to trauma, especially burns or other tissue damage leading to inflammation.

Further Reading

Study assesses the efficacy and safety of lithium treatment in patients infected with severe SARS-CoV-2

Study assesses the efficacy and safety of lithium treatment in patients infected with severe SARS-CoV-2

5 May 2022
Clinical characteristics of immunocompromised patients infected with the SARS-CoV-2 Omicron variant

Clinical characteristics of immunocompromised patients infected with the SARS-CoV-2 Omicron variant

29 Apr 2022
Study highlights a rapidly increasing patient population with long COVID and lack of treatments

Study highlights a rapidly increasing patient population with long COVID and lack of treatments

24 Apr 2022
Interleukin-6 levels predict early withdrawal of COVID-19 patients from mechanical ventilation

Interleukin-6 levels predict early withdrawal of COVID-19 patients from mechanical ventilation

22 Apr 2022
Chromatin accessibility as an early marker of severe COVID-19

Chromatin accessibility as an early marker of severe COVID-19

11 Apr 2022
Recombinant fragment of the lectin-binding region of Gal-3BP stimulates the expression of IL-6 in SARS-CoV-2 sensitive cells

Recombinant fragment of the lectin-binding region of Gal-3BP stimulates the expression of IL-6 in SARS-CoV-2 sensitive cells

5 Apr 2022
Study evaluates efficacy of sarilumab in severe/critical COVID-19 patients

Study evaluates efficacy of sarilumab in severe/critical COVID-19 patients

27 Mar 2022
The effect of SARS-CoV-2 on the expression of CD48 in the lungs and in the peripheral blood of COVID-19 patients

The effect of SARS-CoV-2 on the expression of CD48 in the lungs and in the peripheral blood of COVID-19 patients

22 Mar 2022
Glycogen synthase kinase-3 inhibitors found to attenuate COVID-19-associated cytokine storm

Glycogen synthase kinase-3 inhibitors found to attenuate COVID-19-associated cytokine storm

21 Mar 2022
Neutrophils found to initiate COVID-19-associated olfactory epithelial damage in hamsters

Neutrophils found to initiate COVID-19-associated olfactory epithelial damage in hamsters

18 Mar 2022
Study suggests single nucleotide polymorphism in interferon receptor impacts COVID-19 outcomes

Study suggests single nucleotide polymorphism in interferon receptor impacts COVID-19 outcomes

17 Mar 2022
Antimicrobial resistance in COVID-19

Antimicrobial resistance in COVID-19

16 Mar 2022
Study evaluates efficacy of isotretinoin in improving COVID-19 outcomes

Study evaluates efficacy of isotretinoin in improving COVID-19 outcomes

14 Mar 2022
The impact of PLEX on the survival of patients with severe COVID-19 and the effect on the cytokine release syndrome

The impact of PLEX on the survival of patients with severe COVID-19 and the effect on the cytokine release syndrome

14 Mar 2022
Biomedical characterization of quantitative proteomics in a hospitalized cohort of COVID-19 patients

Biomedical characterization of quantitative proteomics in a hospitalized cohort of COVID-19 patients

8 Mar 2022
Pilot study opens the door to a promising new therapeutic alternative for PTSD patients

Pilot study opens the door to a promising new therapeutic alternative for PTSD patients

4 Mar 2022
WHO experts suggest antiviral drug for patients with non-severe covid-19 at highest risk of hospitalization

WHO experts suggest antiviral drug for patients with non-severe covid-19 at highest risk of hospitalization

3 Mar 2022
Adenosine receptor agonists provide therapeutic target in mouse SARS-CoV-2 infection

Adenosine receptor agonists provide therapeutic target in mouse SARS-CoV-2 infection

2 Mar 2022
Metalloproteinase-dependent entry pathway differentially used by SARS-CoV-2 Delta, Alpha, and Omicron variants

Metalloproteinase-dependent entry pathway differentially used by SARS-CoV-2 Delta, Alpha, and Omicron variants

24 Feb 2022
Study shows BCG vaccine provides no protection against SARS-CoV-2 in mice and hamsters

Study shows BCG vaccine provides no protection against SARS-CoV-2 in mice and hamsters

23 Feb 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback